eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Bausch + Lomb - Comment

Bausch + Lomb - Comment

Document ID: FDA-2011-N-0849-0005
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: February 20 2012, at 12:00 AM Eastern Standard Time
Date Posted: February 29 2012, at 12:00 AM Eastern Standard Time
Comment Start Date: December 20 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: February 21 2012, at 11:59 PM Eastern Standard Time
Tracking Number: 80fba604
View Document:  View as format xml

View Comment

See attached file(s)

Attachments:

Bausch + Lomb - Est Timeframe Safety Label Changes_FDA2011-N-0849_20Feb2012

Title:
Bausch + Lomb - Est Timeframe Safety Label Changes_FDA2011-N-0849_20Feb2012

View Attachment: View as format pdf

Related Comments

    View All
Total: 17
Anonymous - Comment
Public Submission    Posted: 02/14/2012     ID: FDA-2011-N-0849-0002

Feb 21,2012 11:59 PM ET
Healthcare Distribution Management Association (HDMA) - Comment
Public Submission    Posted: 02/29/2012     ID: FDA-2011-N-0849-0004

Feb 21,2012 11:59 PM ET
Bausch + Lomb - Comment
Public Submission    Posted: 02/29/2012     ID: FDA-2011-N-0849-0005

Feb 21,2012 11:59 PM ET
Novo Nordisk Inc. - Comment
Public Submission    Posted: 02/29/2012     ID: FDA-2011-N-0849-0006

Feb 21,2012 11:59 PM ET
National Association of Chain Drug Stores (NACDS) - Comment
Public Submission    Posted: 02/29/2012     ID: FDA-2011-N-0849-0007

Feb 21,2012 11:59 PM ET